Vagisan Lactic Acid Bacteria is a medical product that contains live, protective lactic acid bacteria. A new legal regulation* ensures that products with living microorganisms may no longer be marketed as medical products from 2024. The product Vagisan Lactic Acid Bacteria was already approved as a medicinal product before the deadline and will be marketed under the new name Vagisan ProbioFlora Lactic Acid Bacteria.

Vagisan Lactic Acid Bacteria contains the same active ingredients and the same concentration of active ingredients as Vagisan ProbioFlora Lactic Acid Bacteria. Both preparations are therefore equally effective and safe. 

The efficacy and safety of the lactic acid bacteria are unchanged in both the medical device and the medicinal product.

* Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 concerning medical devices, Chapter 1 (6).